A Review On The Guidelines For Nutritional Assessment for HNC (Head and Neck Cancer) Patients Managed By Surgery
Shrikanth Muralidharan1*, Arunkumar Acharya2, Pramila M3, Shanthi Margabandhu4, Seema Kamble5
1 Reader, Department of Public Health Dentistry, Madha Dental College and Hospital, West Tambaram, Chennai, India.
2 Professor and Head, Department of Public Health Dentistry, Navodaya Dental College and Hospital, Raichur, India.
3 Professor and Head, Department of Public Health Dentistry, MR Ambedkar Dental College and Hospital, Bangalore, Karnataka, India.
4 Public Health Dentist, Private Practitioner, Bangalore, Karnataka, India.
5 Associate Professor, Department of Public Health Dentistry, Nair Dental College, Mumbai, India.
*Corresponding Author
Dr. Shrikanth Muralidharan,
Reader, Department of Public Health Dentistry, Madha Dental College and Hospital, West Tambaram, Chennai, India.
Tel: 8308008831
E-mail: Shrikanthmuralidharan23@gmail.com
Received: February 05, 2021; Accepted: October 01, 2021; Published: October 21, 2021
Citation: Shrikanth Muralidharan, Arunkumar Acharya, Pramila M, Shanthi Margabandhu, Seema Kamble. A Review On The Guidelines For Nutritional Assessment for HNC
(Head and Neck Cancer) Patients Managed By Surgery. Int J Dentistry Oral Sci. 2021;8(10):4784-4789. doi: dx.doi.org/10.19070/2377-8075-21000970
Copyright: Shrikanth Muralidharan©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
There are a number of guidelines to assess the nutrition status of cancer cases. None of these guidelines are specifically Head and Neck (HNC) cancer related; except for the European guidelines. This paper reviews the different guidelines in nutrition for cancer cases and also their drawbacks.
2.Introduction
3.Materials and Methods
3.Results
4.Discussion
5.Conclusion
5.References
Keywords
HNC; Cancer; Nutrition; Guidelines.
Introduction
The The 2019 ESPEN (European Society for Clinical Nutrition
and Metabolism) guideline guidelines state that “early oral feeding
is the preferred mode of nutrition for surgical patients”. It is
essential to consider any risk that may arise out of underfeeding
during the post-operative recovery period. The report provides
certain clinical guidelines which need to be followed especially
while handling complicated cases like cancer. One essential recommendation
is that of early enteral feeding. Its focus is on the
concept of nutritional aspects of the Enhanced Recovery After
Surgery (ERAS). The guidelines call for, “integration of nutrition
into the overall management of the patient”. Nutritional assessment
and dietary recommendations was always a challenge for
such cases [1]. Most of the guidelines have been generic in nature
and not tailor made for Head and Neck Cancer (HNC) patients.
Today newer guidelines are available that can serve to assess the
nutritional requirements of HNC. Dieticians are able to estimate
and achieve the nutritional requirements for HNC patients
through set equations provided for cancer patients.
Guidelines For Nutritional Assessment In Cancer Patients
Nutritional impacts occur due to side effects like taste and smell
alterations, dysphagia, malabsorption, depression, anxiety, nausea
[2]. Hence Nutritional intervention tends to help the patients gain
some weight or at least maintain it and produce better surgical
outcomes. Baseline assessment is important.
A number of screening tools are available which have been validated
among cancer cases (Table 01) [3]. But these are not specific
for HNC patients.
The Subjective global assessment (SGA) assesses nutritional status
is based on the features of a history (weight change, dietary
intake change, gastrointestinal symptoms that have persisted for
greater than 2 weeks, and functional capacity) and physical examination
(loss of subcutaneous fat, muscle wasting, ankle/sacral
edema and ascites). Features are combined subjectively into an
overall or global assessment in which patients are rated as being
well nourished, moderately (or suspected of being) malnourished,
or severely malnourished [4]. PGSGA combines: nutritional
screening , assessment, interventional triage and monitors interventional
success. Even though recommended in different guidelines,
it is not a very oncology specific tool [4].
‘MUST’ is a five-step screening tool to identify adults, who are
malnourished, at risk of malnutrition (undernutrition), or obese.
It also includes management guidelines which can be used to develop
a care plan [5]. The five steps are-
Step 1- Measurement of height and weight to get a BMI score.
Step 2- % of weight loss (unplanned)
Step 3- Acute disease establishment and score.
Step 4- Addition of scores from 1, 2 and 3 to estimate the overall
risk of malnutrition.
Step 5- Use guidelines for management and a care plan development.
A baseline assessment can assist us to identify the risk of deficiency
of critical nutrients, help to formulate nutrition plan tailor
made for specific individuals and monitor its impact at regular
intervals or stages by comparing it with the previous assessment
[6]. For those with different stages of treatment, more planning is
necessary. It has to be monitored and considered separately. The
same assessment may not hold true for all patients [7].
Table 02 shows the nutritional assessment criteria that is recommended
currently [3].
A systematic nutritional risk screening (NRS) has to be considered in all patients on hospital admission. An approach of only
using the body weight as the lone indicator of malnourishment is
ineffective since the epidemic of global obesity is on the rise and
also there are other metabolic alterations which take place before
appreciable change in the body weight [8].
HNC Surgery and Malnourishment
When there is an inadequate intake orally for more than 14 days, it
is associated with a high mortality risk. Cancer patients who have
a high nutritional risk must receive nutrition based support for
10 to 14 days before any major surgery [3]. In severe cases when
possibility of difficulty in eating will persist for more than 7 days,
enteral nutrition is always indicated perioperatively [3]. It is also
recommended that in case where the food intake is anticipated
to be inadequate for more than 10 days then enteral nutrition is
recommended. Gastrostomy insertion is done in case feeding is
essential via tube for more than 4 weeks [3]. Post- surgical swallowing
problems are quite commonly encountered in HNC cases
[9]. Post surgically, HNC cases undergo alterations in the short
and long term swallowing pattern which subsequently requires
enteral feeding [10]. With a compromised deglutition functioning,
maintaining a nutrition balance is a big challenge in such cases
[11]. A multicentric study reported that pain and scar in the region
of surgery may dissuade the patients from consuming food
normally. Those with more than 10 kg of weight loss post surgically
were more dependent on mashed food [12]. There was only
one study showing positively more cases (60%) who were able to
tolerate normal or soft diet and not dependent on tube feeding in
less than 2 months of surgery. The authors state that, after a partial
mandibulectomy procedure, a good reconstruction and early
intervention for obtaining occlusion and normal functioning is
the key to avoid nutrition associated complications in such surgeries
[13]. So dietary plan should be part of the routine discharge
summary and rehabilitative procedure for HNC cases undergoing
surgery.
Guidelines For Estimating Nutritional Requirements Among Cancer Patients
An initial method of estimating Basal Metabolic Rate (BMR) for
adults was proposed by Schofield in 1985 [14]. The equations are
as follows-
The actual energy needed per day (ERR) can be calculated from
the BMR after multiplying it by an activity factor as shown in
Table 05-
In cancer cases, the Total Energy Expenditure (TEE) is also estimated
using the formula-
TEE = Resting Energy Expenditure (REE)+ activity-associated
energy expenditure.
The drawback of using this formula is that it is not specific to
HNC. REE is elevated in cases of cancer but in advanced cases
due to fatigue and reduced physical activities lead to decrease in
TEE [15]. Hence neither REE nor TEE can serve as an accurate
prediction in HNC. Indirect calorimetric measurements serve as
an accurate predictor for REE and is considered for all patients
who are at- risk for malnourishment [16].
Another recommended target range to maintain or restore the
lean body mass is 25- 30 kcal/kg/day with 1.2 to 1.5 grams of
protein/kg/day. In severely depleted cases, higher protein supply
may be required [17].
The Glasgow Prognostic Score (GPS), which includes the serum
levels of C- reactive proteins as well as albumin, serves as a highly
predictable tool for inflammation in cancer patients [18]. This rise
in inflammation may be reactionary to the tumour growth and
serves as a marker for overall survival of the patients [19].
Rayan and colleagues suggested that a retrospective analysis of
the computed tomographic records can also help to detect the
muscle mass loss and the fatty muscle infiltration [20].
The latest ESPEN guidelines recommend the following 8-
1. Screen each patient's nutritional status early in the course of
cancer treatment.
2. Identify signs or symptoms of anorexia, cachexia, and sarcopenia
at the earliest.
3. Use of CT scan for detecting sarcopenia.
4. Use of specific biomarkers like CRP and albumin to assess cancer
related systemic inflammation, e.g. CRP and albumin.
5. Use indirect calorimetry to estimate REE to personalize protein
and energy needs.
6. Use nutrition and metabolic support as a vital part of cancer
care.
7. Assess physical function routinely to monitor and guide physical
rehabilitation.
Even though multiple methods have been suggested, these methods
of estimation of nutrition are not very specific to the HNC
cases. Hence a common consensus regarding their utilization in
day-to-day practise is missing in literature.
Cancer and its treatment approaches therefore affect the nutritional
status by altering the metabolic function and reduced food
intake. Dietary supplements and fortified foods are used by patients
as an adjunct to standard treatment. Evidence for international
guidelines specifically for the type of HNC is missing.
Hence one size fits all may not be true for such cases. Hence a
common guideline, specifically for HNC cases separately is essential
to assist the dieticians in formulation of diet counselling
sessions and advisories in HNC patients.
Thus reduced nutritional status can be seen from the initial diagnosis
which may exacerbate due to treatment related toxicities.
Complications arising out of this may persist for a longer duration.
Hence assessment of the nutritional status must be a part
of the routine monitoring process for HNC patients. An early
intervention can help to minimize the co morbidities associated
with HNC treatment [21]. The European recommendations are
the only set of guidelines that focus on HNC patients. Even
though other guidelines are there, they are more general and not
pertaining to a particular system affected or the specific therapy
for cancer.
HNC patients are different from the other cancer types, due to
the complex nature of the systems involved. Major chances of
complications (local and systemic) can arise post HNC surgery
like scar, pain, delayed wound healing, localized infection. Nutrition
assessment of these patients is essential part of a multi-disciplinary
approach to treatment. A failure of such an assessment
can increase the complications and increase mortality rates. This
assessment forms a part of pre as well as post-surgical period.
Studies have reported quite contrasting outcomes with respect to
the assessment techniques as well as the routes feeding. Different
schools of thoughts can result in a neglected role of dietician in
cancer therapy and also delay the physical as well as psychological
healing of the patients; and also their quality of life, where diet
is an important component. The recent ESPEN guidelines have
been proposed for assessment for HNC cases, very little evidence
is present on the feasibility of these guidelines to be used as an
integral part of day to day practise.
Prior to the 2019 guidelines, specific assessment cut offs were not
available for HNC patients undergoing any form of therapy. The
assessment criteria were more generic than specific.At an institutional
level, the ESPEN guidelines can serve to propose a better
assessment of HNC patients and aid in more subjective and uniform
evaluation of the nutritional intervention therapy.
Clinically the loss of weight or a low BMI usually indicate cachexia/
anorexia clinically [2]. Weight changes are not always associated
with nutrition intake alone. BMI does account for the
fluid loss like in dehydration or for a loss of body mass that makes
a patient extremely lean [22]. Since BMI does not take into account
the body composition, it at times can be misleading and
false negative results may be generated [23]. There is always a possibility
that cancer patients may present with normal body weight
but sarcopenia may be severe in them. (I did not find any specific tool apart from BMI that was used for sarcopenia) So BMI cannot
always be regarded as a lone gold standard for assessment
sake 24. Serum albumin levels are changed in cancer cases; but
these indicate the severity of any underlying inflammation rather
than the severity of the disease itself. Their levels may not always
be altered in all cancer cases due to the disease condition or the
therapy provided alone [25]. The initial problem is that there is a
complete lack of epidemiological data in terms of malnutrition
related to HNC cancer [26]. Hence one does not always know
the exact severity of the prevalence of malnutrition among HNC
patients. The newer guidelines are an attempt to overcome this
hurdle. There is a lack of uniform assessment pattern across the
different hospitals curtailing to the needs of HNC patients; which
was always a challenge. Taking an overall anthropometric measurement
for all cases may not be feasible and is time consuming
in the ward. Hence a total assessment of the body composition is
also missed during the routine clinical examinations for HNC patients
[27]. One size fits all rule also cannot be followed in HNC
cases due to the complexity of the anatomical structures involved
and also the different types of cancer and the combination of
therapeutic options used for treatment purposes.
The PENG 2019 guidelines estimates the nutritional requi
rements
for the cancer patients overall, but whether it is true for all
those patients with different therapeutic interventions is yet not
evident.A recent study reported that just meeting the minimum
requirements as per the ESPEN guidelines may not attenuate loss
of skeletal muscle in HNC patients [28]. The severity of the cancer,
type of surgery and the post-surgical interventions should
also be considered while the nutritional assessment is being done.
End stage patients may need more interventions comparatively.
Nutritional assessment should be therefore more holistic and not
focus only on achieving a particular cut- off criteria. The nutritional
assessment should also be part of the routine home based
care.
In order to establish an accurate REE for patients, it is essential
to understand the actual energy requirements by the patients.
Only this can provide a better insight into an actual maintenance
and overcome complications arising due to inadequate nutrition
supply. This REE which is usually higher in cancer cases (more
than 70%) is influenced by a variety of factors such as age of
the patients, gender, fat free mass and the total body mass [25].
An increase in the physical activity of the patients can further increase
REE. So the calculations have to be custom made again per
patient. One can measure the REE by using the Harris–Benedict
equation(HB) or the indirect calorimetry (IC). A study by Gracia-
Peris and colleagues reported that using HB for BMR calculation
is not always accurate in chemotherapy patients as compared
to IC. So they suggest that IC is a gold standard technique than
the HB equation [29]. In surgical cases of HNC, there are no
literature reports if HB is a valid formula for estimation of BMR.
Hence more studies are needed for stronger evidence. In case of
advanced surgery, recovery phases may be prolonged along with
the duration of hospital stay, testing the newer PENG guidelines
for such cases is essential. Variability with respect to nutritional requirement
and also the response to the nutritional therapy can be
expected in relation to the type of tumour, surgical technique and
also the age and gender of the patients. The nutritional assessment
as per the new PENG guidelinesmay be different for cases
which undergo chemo and radiotherapy also apart from surgery.
Hence more evidence is required for case-based utilization of the
guidelines. Different equations for assessment and cut off criteria
may be required for cases which undergo only surgery and for
cases which may require surgery and chemoradiotherapy.
BMI is the mainly used indicator for weight loss and indirectly
correlates to malnourishment, using the same cut-off range for
the non- cancer patients may require further review. All patients
with cancer undergo alteration in the BMI. Hence a basic criterion
for BMI classification for cancer patients and especially HNC cases
is highly recommended. Therefore a patient, who already had a
low BMI at the baseline, is more likely have low BMI score postsurgery.
So the nutritional requirements should consider such a
scenario while determining the outcomes.
Using the same assessment method for different categories of
cancer is questionable. More evidence is needed for determining
the sensitivity and specificity of the tool. If the newer guidelines
are being used for estimation, then the chart for entries needs
to be redrawn with a proper training and appraisal regarding the
need to do so. The guidelines do not state any separate method
for cases which need increased length of the hospital stay. Under
such circumstances, a prolonged stay may be associated with better
nutritional outcomes rather than home based care 30.Some
of the equations previously used for nutritional assessments were
generated by estimating the requirements in adult young participants.
Hence this needs to be validated for its use in older individuals
also.
Recommendations
1. Maintenance of food records is essential. Oncologists or nursing
staffs may alter the food intake (quantity, nature) based on the
request and condition of the patient. Example- a case undergoing
glossectomy may need pureed food, since chewing and swallowing
is a major challenge. So such specifications must be put on paper
and additional help must be sought for the long term benefit
of the patients.
2. The current guidelines do not take into account the different
classes of BMI. But cancer specific cut offs for BMI are required
with respect to BMI since it is a major part of the assessment
criteria.
3. It is recommended to have a robust study with an idea case
scenario where the sample size is large enough for statistically significant
data. Also it needs to involve people with different races,
have both male and female patients, and the cases matched for the
type of cancer categorization. Performing an actual nutritional intervention
using blinding can provide stronger evidence. This can
help to provide more information about the assessment criteria
specific for age, gender and also the type of cancer.
4. It may be ideal to have followed up of the cases to determine
the weight gain, change in the body mass (from lean to healthy),
REE and protein intake.
References
-
[1]. Shetty S, Kattappagari KK, Hallikeri K, Krishnapilli R. Evaluation of oral
lesions in HIV seropositive individuals and its correlation with CD4+ Tlymphocytic
count. Journal of Dr. NTR University of Health Sciences. 2016
Apr 1;5(2):123.
[2]. Chaurasia A. CD4+ counts and Oral Lesions in HIV infected/AIDS patientsan Indian Perspective. Juniper online Journal of Case Study. 2017;1(5):1-2.
[3]. Denny CE, Ramapuram J, Bastian TS, Ongole R, Binnal A, Natarajan S. Oral lesions in HIV/AIDS patients on highly active antiretroviral therapy. World Journal of Dentistry. 2016 Apr 1;7(2):95-9.
[4]. Arirachakaran P, Hanvanich M, Kuysakorn P, Thongprasom K. Antiretroviral Drug-Associated Oral Lichenoid Reaction in HIV Patient: A Case Report. Int J Dent. 2010;2010:291072. Pubmed PMID: 20671969.
[5]. Heron SE, Elahi S. HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation. Front Immunol. 2017 Mar 7;8:241. Pubmed PMID: 28326084.
[6]. Leao JC, Ribeiro CM, Carvalho AA, Frezzini C, Porter S. Oral complications of HIV disease. Clinics (Sao Paulo). 2009 May;64(5):459-70. Pubmed PMID: 19488613.
[7]. Jayakaran TG. The effect of drugs in the oral cavity-A review. Journal of pharmaceutical sciences and research. 2014 Feb 1;6(2):89.
[8]. Max B, Sherer R. Management of the adverse effects of antiretroviral therapy and medication adherence. Clin Infect Dis. 2000 Jun;30 Suppl 2:S96-116. Pubmed PMID: 10860894.
[9]. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med. 2004 Jul 1;15(4):221-39. Pubmed PMID: 15284187.
[10]. Shrivastava S, Ts B, Singh A, Singh S. ADVERSE EFFECTS OF ANTIRETROVIRAL THERAPY ON ORAL TISSUES IN HIV POSITIVE INDIVIDUALS. Oral & Maxillofacial Pathology Journal. 2013 Jan 1;4(1).
[11]. Yuan A, Woo SB. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jan;119(1):35-47. Pubmed PMID: 25442252.
[12]. Krishna AB, Gannepalli A, Baghirath PV, Khaled S, Shailaja S, Anuradha C. Age-related - oral manifestations and co-morbidities in human immunodeficiency virus-infected/acquired immune deficiency syndrome adults in Hyderabad, India. Indian J Dent Res. 2015 Jul-Aug;26(4):351-5. Pubmed PMID: 26481879.
[13]. Chakraborty N, Mukherjee A, Santra S, Sarkar RN, Banerjee D, Guha SK, et al. Current trends of opportunistic infections among HIV-seropositive patients from Eastern India. Jpn J Infect Dis. 2008 Jan;61(1):49-53. Pubmed PMID: 18219134.
[14]. Saha K, Firdaus R, Santra P, Pal J, Roy A, Bhattacharya MK, et al. Recent pattern of Co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata. Virol J. 2011 Mar 14;8:116. Pubmed PMID: 21396133. [15]. Kumar S, Gowda S, Basavarajaiah. Incidence of Oral candidiasis among HIV infected. Int J Sci Res Publ. 2013;3(12):1-6.
[16]. Muralidharan S, Acharya AK, Margabandhu S, Kalekhan S, Ahsan S, Kulkarni D. Prevalence of Periodontitis and Soft Tissue Lesions among Human Immunodeficiency Virus-positive Patients on Antiretroviral Therapy in Raichur Taluk, Karnataka, India. J Contemp Dent Pract. 2018 Jan 1;19(1):42-46. Pubmed PMID: 29358533.
[17]. Panda S, Kamei G, Pamei M, Sarkar S, Sarkar K, Singh ND, et al. Clinical features of HIV infection in drug users of Manipur. Natl Med J India. 1994 Nov-Dec;7(6):267-9. Pubmed PMID: 7841877.
[18]. Shrimali Lalit. A Study Of Oral Manifestation Of HIV / AIDS. Int J Oral Maxillofac Pathol. 2010;1:8-12.
[19]. Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci. 2011 Jun;53(2):203- 11. Pubmed PMID: 21712625.
[20]. Hegde MN, Hegde ND, Malhotra A. Prevalence of oral lesions in HIV infected adult population of Mangalore, Karnataka, India. Biodiscovery. 2012 Oct 23;4:e8935.
[21]. Rao UK, Ranganathan K, Kumarasamy N. Gender differences in oral lesions among persons with HIV disease in Southern India. J Oral Maxillofac Pathol. 2012 Sep;16(3):388-94. Pubmed PMID: 23248472.
[22]. Annapurna CS, Prince CN, Sivaraj S, Ali IM. Oral manifestations of HIV patients in South Indian population. J Pharm Bioallied Sci. 2012 Aug;4(Suppl 2):S364-8. Pubmed PMID: 23066291.
[23]. Jindwani K, Singh K, Dadlani H. A study of oral lesions among HIV positives in a tertiary care hospital.
[24]. Kumar S, Mishra P, Warhekar S, Airen B, Jain D, Godha S. Oral Health Status and Oromucosal Lesions in Patients Living with HIV/AIDS in India: A Comparative Study. AIDS Res Treat. 2014;2014:480247. Pubmed PMID: 25215229.
[25]. Sanadhya YK, Sanadhya S, Nagarajappa R, Jain S, Aapaliya P, Sharma N. Correlation between oral lesions and opportunistic infections among human immunodeficiency virus - infected individuals in Indian population. Int Marit Health. 2014;65(3):124-30. Pubmed PMID: 25471161.
[26]. Ravi JR, Rao TR. Estimation of prevalence of periodontal disease and oral lesions and their relation to CD4 counts in HIV seropositive patients on antiretroviral therapy regimen reporting at District General Hospital, Raichur. J Indian Soc Periodontol. 2015 Jul-Aug;19(4):435-9. Pubmed PMID: 26392694.
[27]. Patil N, Chaurasia VR, Babaji P, Ramesh D, Jhamb K, Sharma AM. The effect of highly active antiretroviral therapy on the prevalence of oral manifestation in human immunodeficiency virus-infected patients in Karnataka, India. Eur J Dent. 2015 Jan-Mar;9(1):47-52. Pubmed PMID: 25713484.
[28]. Hegde V, Shetty PJ, Alva S, Chengappa SK. Assessment of dental caries experience, periodontal status, and oral mucosal lesions among human immunodeficiency virus seropositives with and without antiretroviral therapy: A cross-sectional study. Journal of Indian Association of Public Health Dentistry. 2016 Jan 1;14(1):46.
[29]. Usha H, Naik B. Comparison of oral lesions in HIV patients with and without highly active antiretroviral therapy visiting government hospitals in Bengaluru city. J Evid Based Med Healthc. 2017;4(20):1141-1147.
[30]. Dongade S, Sermadi ZM, Manjunath R, Priyadarshini C, Jayapala MS. Prevalence of oral manifestations among hiv-positive patients undergoing antiretroviral treatment visiting Chamarajanagar district hospital: A crosssectional study. Journal of Indian Academy of Oral Medicine and Radiology. 2017 Oct 1;29(4):288.